Blinatumomab 17504-0011-01
- Manufacturer
- Lonza Biologics, Plc
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- December 18, 2014
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Blinatumomab | 55 ug/mL |
Selected Package
17504-0011-01Selected4234 mL in 1 BOTTLE (17504-0011-1)